Novavax is one of the pharmaceutical companies that is delaying the launch of its vaccine, due to regulatory issues, other pharmaceutical companies such as Pfizer, modern, astrazeneca and j & j (janssen) have an advantage.
There is a potential to buy shares of this American pharmaceutical company, due to the demand for its vaccine in different countries, the ones that stand out for its large population is India, which has approximately 1,300 million people and that needs vaccines to immunize the great Most of the population, India is one of the countries that have been most affected and 39% of its population has been vaccinated with a single dose, mostly of astrazeneca, what I find interesting for Novavax is that it has a agreement with the largest vaccine factory in India and the world and is the Serum Institute of India (SII)
There is a potential to buy shares of this American pharmaceutical company, due to the demand for its vaccine in different countries, the ones that stand out for its large population is India, which has approximately 1,300 million people and that needs vaccines to immunize the great Most of the population, India is one of the countries that have been most affected and 39% of its population has been vaccinated with a single dose, mostly of astrazeneca, what I find interesting for Novavax is that it has a agreement with the largest vaccine factory in India and the world and is the Serum Institute of India (SII)